In the report by Leong et al., a community-based study of an all-women cohort [ 64 ], the risk for all-cause mortality was slightly higher with higher ADMA levels, but did not reach statistical significance after 24 years of follow-up.
← all excerpts
Biomarkers representing key aging-related biological pathways are associated with subclinical atherosclerosis and all-cause mortality: The Framingham Study.
1
—
—